Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report
Venous thromboembolism (VTE) is a significant issue occurring due to genetic, acquired and circumstantial risk factors. Treatment is according to the clinical situation and judgment for long term anticoagulation based on individual risk. Anticoagulation after a history of a hemorrhagic stroke poses...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2020-01, Vol.12 (1), p.e6746 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | e6746 |
container_title | Curēus (Palo Alto, CA) |
container_volume | 12 |
creator | Ajmeri, Aman N Zaheer, Kamran McCorkle, Colin Amro, Ahmed Mustafa, Bisher |
description | Venous thromboembolism (VTE) is a significant issue occurring due to genetic, acquired and circumstantial risk factors. Treatment is according to the clinical situation and judgment for long term anticoagulation based on individual risk. Anticoagulation after a history of a hemorrhagic stroke poses a therapeutic dilemma. We present a case of a 68-year-old male who presented with right-sided chest pain and shortness of breath. Workup included a CT that was positive for multiple right-sided pulmonary emboli (PE). The patient has a past medical history of Factor V Leiden Mutation, recurrent PE, and deep vein thrombosis (DVT). Two months prior he was diagnosed with a 1.3-cm intracranial hemorrhage (ICH) from multiple cavernous angiomas. At that time his warfarin was discontinued and an inferior vena cave (IVC) filter was placed. Facing the recent ICH and now multiple and recurrent PE, it was decided to resume anticoagulation based on ICH location. ICH from a deep source is likely a better characteristic that favors a resumption of anticoagulation. Our case will highlight that IVC filters cannot be solely relied upon in patients that are at high risk for thrombotic events with underlying genetic thrombophilia. |
doi_str_mv | 10.7759/cureus.6746 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7034755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384681701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c264t-5166e6e12652a103eca35c35d914cbb138f5ed8b4d2b5373dfe743743c99698a3</originalsourceid><addsrcrecordid>eNpVkM1Lw0AQxRdRrNSevEvAo6TuR_YjHoRS1BYLilSvy2YzaVOabN1NBP97U1pLhRlmYB5vHj-ErggeSsnTO9t6aMNQyEScoAtKhIoVUcnp0d5DgxBWGGOCJcUSn6Meo4QxKtQFepl7ME1ZL6JPqF0bovnSuypz0PW6DFX05kITTevGG-tNXZp1NIHKeb80C7iPRtHYBIjeYeN8c4nOCrMOMNjPPvp4epyPJ_Hs9Xk6Hs1iS0XSxJwIAQIIFZwaghlYw7hlPE9JYrOMMFVwyFWW5DTjTLK8AJmwrmyailQZ1kcPO99Nm1WQW9imW-uNLyvjf7Qzpf5_qculXrhvLTFLJOedwc3ewLuvFkKjV671dZdZU6YSoYjEpFPd7lTWuxA8FIcPBOstfL2Dr7fwO_X1caiD9g81-wXtVYFW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2384681701</pqid></control><display><type>article</type><title>Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Ajmeri, Aman N ; Zaheer, Kamran ; McCorkle, Colin ; Amro, Ahmed ; Mustafa, Bisher</creator><creatorcontrib>Ajmeri, Aman N ; Zaheer, Kamran ; McCorkle, Colin ; Amro, Ahmed ; Mustafa, Bisher</creatorcontrib><description>Venous thromboembolism (VTE) is a significant issue occurring due to genetic, acquired and circumstantial risk factors. Treatment is according to the clinical situation and judgment for long term anticoagulation based on individual risk. Anticoagulation after a history of a hemorrhagic stroke poses a therapeutic dilemma. We present a case of a 68-year-old male who presented with right-sided chest pain and shortness of breath. Workup included a CT that was positive for multiple right-sided pulmonary emboli (PE). The patient has a past medical history of Factor V Leiden Mutation, recurrent PE, and deep vein thrombosis (DVT). Two months prior he was diagnosed with a 1.3-cm intracranial hemorrhage (ICH) from multiple cavernous angiomas. At that time his warfarin was discontinued and an inferior vena cave (IVC) filter was placed. Facing the recent ICH and now multiple and recurrent PE, it was decided to resume anticoagulation based on ICH location. ICH from a deep source is likely a better characteristic that favors a resumption of anticoagulation. Our case will highlight that IVC filters cannot be solely relied upon in patients that are at high risk for thrombotic events with underlying genetic thrombophilia.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.6746</identifier><identifier>PMID: 32133268</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Anticoagulants ; Case reports ; Health risk assessment ; Internal Medicine ; Mutation ; Neurology ; Pulmonary embolisms ; Pulmonology ; Thromboembolism</subject><ispartof>Curēus (Palo Alto, CA), 2020-01, Vol.12 (1), p.e6746</ispartof><rights>Copyright © 2020, Ajmeri et al.</rights><rights>Copyright © 2020, Ajmeri et al. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020, Ajmeri et al. 2020 Ajmeri et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034755/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034755/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32133268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ajmeri, Aman N</creatorcontrib><creatorcontrib>Zaheer, Kamran</creatorcontrib><creatorcontrib>McCorkle, Colin</creatorcontrib><creatorcontrib>Amro, Ahmed</creatorcontrib><creatorcontrib>Mustafa, Bisher</creatorcontrib><title>Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Venous thromboembolism (VTE) is a significant issue occurring due to genetic, acquired and circumstantial risk factors. Treatment is according to the clinical situation and judgment for long term anticoagulation based on individual risk. Anticoagulation after a history of a hemorrhagic stroke poses a therapeutic dilemma. We present a case of a 68-year-old male who presented with right-sided chest pain and shortness of breath. Workup included a CT that was positive for multiple right-sided pulmonary emboli (PE). The patient has a past medical history of Factor V Leiden Mutation, recurrent PE, and deep vein thrombosis (DVT). Two months prior he was diagnosed with a 1.3-cm intracranial hemorrhage (ICH) from multiple cavernous angiomas. At that time his warfarin was discontinued and an inferior vena cave (IVC) filter was placed. Facing the recent ICH and now multiple and recurrent PE, it was decided to resume anticoagulation based on ICH location. ICH from a deep source is likely a better characteristic that favors a resumption of anticoagulation. Our case will highlight that IVC filters cannot be solely relied upon in patients that are at high risk for thrombotic events with underlying genetic thrombophilia.</description><subject>Anticoagulants</subject><subject>Case reports</subject><subject>Health risk assessment</subject><subject>Internal Medicine</subject><subject>Mutation</subject><subject>Neurology</subject><subject>Pulmonary embolisms</subject><subject>Pulmonology</subject><subject>Thromboembolism</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkM1Lw0AQxRdRrNSevEvAo6TuR_YjHoRS1BYLilSvy2YzaVOabN1NBP97U1pLhRlmYB5vHj-ErggeSsnTO9t6aMNQyEScoAtKhIoVUcnp0d5DgxBWGGOCJcUSn6Meo4QxKtQFepl7ME1ZL6JPqF0bovnSuypz0PW6DFX05kITTevGG-tNXZp1NIHKeb80C7iPRtHYBIjeYeN8c4nOCrMOMNjPPvp4epyPJ_Hs9Xk6Hs1iS0XSxJwIAQIIFZwaghlYw7hlPE9JYrOMMFVwyFWW5DTjTLK8AJmwrmyailQZ1kcPO99Nm1WQW9imW-uNLyvjf7Qzpf5_qculXrhvLTFLJOedwc3ewLuvFkKjV671dZdZU6YSoYjEpFPd7lTWuxA8FIcPBOstfL2Dr7fwO_X1caiD9g81-wXtVYFW</recordid><startdate>20200122</startdate><enddate>20200122</enddate><creator>Ajmeri, Aman N</creator><creator>Zaheer, Kamran</creator><creator>McCorkle, Colin</creator><creator>Amro, Ahmed</creator><creator>Mustafa, Bisher</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20200122</creationdate><title>Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report</title><author>Ajmeri, Aman N ; Zaheer, Kamran ; McCorkle, Colin ; Amro, Ahmed ; Mustafa, Bisher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c264t-5166e6e12652a103eca35c35d914cbb138f5ed8b4d2b5373dfe743743c99698a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anticoagulants</topic><topic>Case reports</topic><topic>Health risk assessment</topic><topic>Internal Medicine</topic><topic>Mutation</topic><topic>Neurology</topic><topic>Pulmonary embolisms</topic><topic>Pulmonology</topic><topic>Thromboembolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ajmeri, Aman N</creatorcontrib><creatorcontrib>Zaheer, Kamran</creatorcontrib><creatorcontrib>McCorkle, Colin</creatorcontrib><creatorcontrib>Amro, Ahmed</creatorcontrib><creatorcontrib>Mustafa, Bisher</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ajmeri, Aman N</au><au>Zaheer, Kamran</au><au>McCorkle, Colin</au><au>Amro, Ahmed</au><au>Mustafa, Bisher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2020-01-22</date><risdate>2020</risdate><volume>12</volume><issue>1</issue><spage>e6746</spage><pages>e6746-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Venous thromboembolism (VTE) is a significant issue occurring due to genetic, acquired and circumstantial risk factors. Treatment is according to the clinical situation and judgment for long term anticoagulation based on individual risk. Anticoagulation after a history of a hemorrhagic stroke poses a therapeutic dilemma. We present a case of a 68-year-old male who presented with right-sided chest pain and shortness of breath. Workup included a CT that was positive for multiple right-sided pulmonary emboli (PE). The patient has a past medical history of Factor V Leiden Mutation, recurrent PE, and deep vein thrombosis (DVT). Two months prior he was diagnosed with a 1.3-cm intracranial hemorrhage (ICH) from multiple cavernous angiomas. At that time his warfarin was discontinued and an inferior vena cave (IVC) filter was placed. Facing the recent ICH and now multiple and recurrent PE, it was decided to resume anticoagulation based on ICH location. ICH from a deep source is likely a better characteristic that favors a resumption of anticoagulation. Our case will highlight that IVC filters cannot be solely relied upon in patients that are at high risk for thrombotic events with underlying genetic thrombophilia.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>32133268</pmid><doi>10.7759/cureus.6746</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2020-01, Vol.12 (1), p.e6746 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7034755 |
source | PubMed Central Open Access; PubMed Central |
subjects | Anticoagulants Case reports Health risk assessment Internal Medicine Mutation Neurology Pulmonary embolisms Pulmonology Thromboembolism |
title | Treating Venous Thromboembolism Post Intracranial Hemorrhage: A Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A18%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treating%20Venous%20Thromboembolism%20Post%20Intracranial%20Hemorrhage:%20A%20Case%20Report&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Ajmeri,%20Aman%20N&rft.date=2020-01-22&rft.volume=12&rft.issue=1&rft.spage=e6746&rft.pages=e6746-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.6746&rft_dat=%3Cproquest_pubme%3E2384681701%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2384681701&rft_id=info:pmid/32133268&rfr_iscdi=true |